The U.S. healthcare system is facing an alarming crisis: a severe shortage of hospital staff, particularly nurses. According to the American Association of Colleges of Nursing (AACN), the demand for registered nurses (RNs) is projected to grow by 6% from 2022 to 2032, yet the supply remains insufficient. The COVID-19 pandemic only exacerbated the issue, leading to widespread burnout, early retirements, and a wave of career departures. Meanwhile, restrictive policies and outdated regulations hinder hospitals from deploying innovative solutions to address the crisis.

This staffing shortfall impacts patient care quality, hospital efficiency, and the well-being of existing healthcare professionals. But two key tangible solutions stand out: expanding virtual nursing education and cutting unnecessary bureaucratic red tape to enable workforce mobility and innovation.

The Center for Telehealth and e-Health Law (CTeL) proudly honors Dr. Andrew Taylor, Director of Artificial Intelligence for the Department of Emergency Medicine at Yale School of Medicine, with the 2025 Tr-AI-lblazer Award.

Dr. Taylor is recognized for his groundbreaking work in AI-driven healthcare, advancing clinical decision support, emergency care efficiency, and health equity. His innovations in machine learning, predictive analytics, and large language models have led to major breakthroughs, including real-time sepsis detection, opioid use disorder surveillance, and AI-assisted dementia recognition.

This award celebrates Dr. Taylor’s leadership in ensuring AI remains ethical, transparent, and transformative in improving patient outcomes.

Heart disease remains the leading cause of death in the U.S., yet early detection and timely intervention can save countless lives. Every 33 seconds, someone dies from heart disease, and nearly 68% of heart failure patients go undiagnosed in primary care settings.

Advanced remote monitoring technologies like Eko Health’s Sensora AI platform are changing this reality.

Through strategic partnerships, such as the collaboration between Eko Health and CTeL, healthcare providers are leveraging AI-powered tools to detect conditions like valvular heart disease, atrial fibrillation, and low ejection fraction—before symptoms become life-threatening.

Studies show that remote patient monitoring significantly improves outcomes, especially in underserved communities where cardiovascular disease often goes undiagnosed.

Access to these life-saving innovations should not be limited by outdated policies or reimbursement barriers. As the healthcare industry advances, policymakers must support innovation by ensuring reimbursement structures encourage adoption, not restrict it.

Miss Fern’s story (https://vimeo.com/1021153175) is a testament to what’s possible: diagnosed early with life-threatening valve disease, she received timely intervention and now has the same life expectancy as someone without the condition. Without access to Sensora’s real-time AI analysis, her condition could have gone unnoticed until it was too late.

Now is the time to push for policies that expand access to AI-driven diagnostic tools, remove barriers to innovation, and support equitable healthcare solutions. The future of cardiac care depends on it.

The House Budget Committee has released a budget resolution outlining significant fiscal changes, sparking a national debate about the future of healthcare access in the United States. The framework proposes $4.5 trillion in tax cuts and a $4 trillion increase to the debt limit, balanced by substantial spending reductions, primarily targeting Medicaid and, to a lesser extent, Medicare. This move has ignited concerns among healthcare advocates and beneficiaries, while proponents argue it’s a necessary step towards fiscal responsibility.

In a recent court ruling, the United States District Court for the Eastern District of California dismissed a constitutional challenge against the state’s medical licensing requirements. The lawsuit, brought by Dr. Sean McBride and patient G. Shellye Horowitz, sought to challenge California’s mandate that all doctors treating patients in the state—whether in person or via telehealth—must obtain a California medical license.

The House Ways and Means Health Subcommittee recently convened a pivotal hearing on "Modernizing American Health Care: Creating Healthy Options and Better Incentives." As chronic diseases skyrocket and access to care remains a pressing concern, the hearing examined innovative solutions, policy roadblocks, and the role of technology in shaping the future of American health care.

Congress's failure to pass a Continuing Resolution (CR) that includes an extension of telehealth flexibilities will have far-reaching and detrimental consequences across the healthcare landscape. The current pause on certain telehealth restrictions, crucial for maintaining access to care during the pandemic, is set to expire. Without Congressional action, we face a "telehealth cliff" with significant repercussions for patients, providers, and the healthcare system as a whole.

Imagine receiving a prescription for a custom-made medication from a telehealth provider you’ve never met in person—one that bypasses the traditional pharmacy system, lacks FDA oversight, and could put your health at risk.

With the rapid rise of telehealth, compounded medications have entered a legal gray area, creating concerns about patient safety, drug efficacy, and regulatory enforcement. While telehealth has expanded access to care, it has also made it easier for unscrupulous actors to exploit regulatory gaps, leading to fraudulent prescribing, substandard medications, and potential harm to patients.

Robert F. Kennedy Jr. recently appeared before the Senate for his confirmation hearing as the nominee for Secretary of the U.S. Department of Health and Human Services (HHS) under the Trump administration. The hearings, held over multiple days, covered a wide range of healthcare policy issues, including chronic disease prevention, vaccine safety, public health transparency, and regulatory oversight.

Notably, Kennedy’s testimony also touched on emerging healthcare technologies, including telehealth, artificial intelligence (AI) in medicine, and digital health innovation. His statements revealed a cautious but open approach to these advancements, emphasizing the need for transparency, accountability, and evidence-based policymaking.

In light of evolving immigration enforcement policies, healthcare providers—including those in telehealth, hospitals, and health systems—must be well-informed about their rights and responsibilities to ensure patient care remains uncompromised. The National Immigration Law Center's January 2025 publication, "Health Care Providers and Immigration Enforcement: Know Your Rights, Know Your Patients’ Rights," offers comprehensive guidance on this subject.

On January 23, 2025, the Office of Management and Budget (OMB) issued Memorandum M-25-13, outlining new guidance for federal agencies to assess financial assistance programs against specific policy directives. These directives influence funding decisions, regulatory compliance, and statutory obligations that may impact CTeL members engaged in telehealth and digital health initiatives.

Agencies administering federal grants and financial assistance programs must now provide detailed responses to a series of policy-related questions before obligating or disbursing funds. CTeL members applying for or currently receiving federal funding should assess how these requirements may affect ongoing and future projects.

The healthcare landscape faces a significant and abrupt challenge following the Office of Management and Budget (OMB)’s recent directive to temporarily pause federal spending on financial assistance programs. This action, effective as of 5:00 PM ET tonight, has wide-ranging implications for healthcare providers, hospitals, and health systems that rely on federal funding to support critical programs.

Telehealth, the delivery of healthcare services through digital communication technologies, has transformed the healthcare landscape. While its rise was accelerated by the COVID-19 pandemic, its long-term financial benefits for both patients and healthcare providers are ensuring its continued growth and integration into modern care models. From cost savings to operational efficiencies, telehealth presents a win-win solution for everyone involved in healthcare delivery.

As the 119th Congress begins its work, the Center for Telehealth and e-Health Law (CTeL) is urging lawmakers to prioritize telehealth in the upcoming reconciliation bill. This legislation represents a unique opportunity to extend critical Medicare telehealth access and address issues like facility fees that could undermine telehealth’s cost-saving potential.

At the Center for Telehealth and e-Health Law (CTeL), we are dedicated to shaping the future of digital health through thoughtful advocacy and research. Recently, we submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding their proposed policies for the Medicare Advantage (MA) and Medicare Prescription Drug programs for contract year 2026. These policies represent a critical opportunity to ensure that emerging technologies like artificial intelligence (AI) are deployed ethically and equitably within healthcare systems.

On January 20, 2025, President Donald Trump signed a series of executive orders with wide-reaching implications across multiple sectors, including healthcare. Among these was the directive to withdraw the United States from the World Health Organization (WHO), a move that could have significant consequences for telehealth, digital health innovation, and global health collaboration. Additionally, the regulatory freeze memorandum signed the same day may further influence telehealth policy and pending waivers.

On January 14, 2025, President Biden issued the Executive Order on Advancing U.S. Leadership in Artificial Intelligence Infrastructure, a bold move to position the United States at the forefront of global AI development. The Center for Telehealth and e-Health Law (CTeL) applauds this initiative as a forward-thinking approach to fostering innovation while ensuring necessary safeguards are in place.

This landmark executive order aims to accelerate the development of AI infrastructure by leveraging federal resources, promoting clean energy, and ensuring equitable access to AI advancements.

The U.S. Drug Enforcement Administration (DEA) has issued a final rule to update and refine regulations surrounding the prescribing of controlled substances via telemedicine, with a particular focus on balancing public health needs and the prevention of substance misuse. This rule is part of an effort to clarify how the practice of telemedicine, which grew significantly during the COVID-19 pandemic, can continue to support patient access to necessary care without compromising the safety measures associated with controlled substances.